Defining targets and protecting normal tissues in inverse-planned IMRT for prostate, head and neck, and gynecologic cancers: A comparative review

Community Oncology

Volumn 2, Issue 4, 2005, Pages 299-306

  Dragun, Anthony E ^a   Harmon, Joseph F ^a,b   Aguero, Eric G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; ESTHESIONEUROBLASTOMA; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NASOPHARYNX CANCER; OROPHARYNX CANCER; PARANASAL SINUS CANCER; PAROTID GLAND CANCER; PROSTATE CANCER; RADIATION ATTENUATION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION PROTECTION; REVIEW; SEMINAL VESICLE; THYROID TUMOR; TUMOR VOLUME;

EID: 23344448962     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70898-1     Document Type: Review

References (43)

1. Nutting C, Dearnaley DP, Webb S. Intensity modulated radiation therapy: a clinical review. Br J Radiol 2000;73:459-469.
2. Mell LK, Roeske JC, Mundt AJ. A survey of intensity-modulated radiation therapy use in the United States. Cancer 2003;98:204-211.
3. Salama JK, Roeske JC, Mehta N, et al. Intensity-modulated radiation therapy in gynecologic malignancies. Curr Treat Options Oncol 2004;5:97-108.
4. Webb S. The physical basis of IMRT and inverse planning. Br J Radiol 2003;76:678-689.
5. Ozyigit G, Yang T, Chao KS. Intensity-modulated radiation therapy for head and neck cancer. Curr Treat Options Oncol 2004;5:3-9.
6. ICRU 50. Prescribing, recording and reporting photon beam therapy. Washington, DC: International Commission on Radiation Units and Measurements; 1993.
7. ICRU 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). Washington, DC: International Commission on Radiation Units and Measurements; 1999.
8. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
9. Guerrero Urbano MT, Nutting CM. Clinical use of intensity-modulated radiotherapy: part II. Br J Radiol 2004;77:177-182.
10. Debus J, Zierhut D, Didinger B, et al. Inverse planning and intensity-modulated radiotherapy in patients with prostate cancer. Front Radiat Ther Oncol 2002;36:25-34.
11. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;12:229-237.
12. Jani AB, Roeske JC, Rash C. Intensity-modulated radiation therapy for prostate cancer. Clin Prostate Cancer 2003;2:98-105.
13. Ling CC, Burman C, Chui CS, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996;35:721-730.
14. Burman C, Chui CS, Kutcher G, et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;39:863-873.
15. Reinstein LE, Wang XH, Burman CM, et al. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 1998;40:207-214.
16. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-249.
17. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-1116.
18. Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 2003;30:2089-2115.
19. Sethi A, Mohideen N, Leybovich L, et al. Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003;55:970-978.
20. Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:465-472.
21. Ryu JK, Winter K, Michalski JM, et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys 2002;54:1036-1046.
22. Morr J, DiPetrillo T, Tsai JS, et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;53:1124-1129.
23. Aubin S, Beaulieu L, Pouliot S, et al. Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID. Med Phys 2003;30:1825-1832.
24. Guerrero Urbano MT, Nutting CM. Clinical use of intensity-modulated radiotherapy: part I. Br J Radiol 2004;77:88-96.
25. Chao KS, Wippold FJ, Ozyigit G, et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002;53:1174-1184.
26. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-916.
27. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:663-673.
28. Vineberg KA, Eisbruch A, Coselmon MM, et al. Is uniform target dose possible in IMRT plans in the head and neck? Int J Radiat Oncol Biol Phys 2002;52:1159-1172.
29. Tsien C, Eisbruch A, McShan D, et al. Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process. Int J Radiat Oncol Biol Phys 2003;55:776-784.
30. Claus F, De Gersem W, De Wagter C, et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int J Radiat Oncol Biol Phys 2001;51:318-331.
31. Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-632.
32. Zabel A, Thilmann C, Zuna I, et al. Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 2002;75:356-361.
33. Nutting CM, Rowbottom CG, Cosgrove VP, et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 2001;60:163-172.
34. Nutting CM, Convery DJ, Cosgrove VP, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 2001;60:173-180.
35. Palta J. Intensity-Modulated Radiation Therapy: The State of the Art. Vol 1. Colorado Springs: Medical Physics Publishing; 2003.
36. Kavanagh BD, Schefter TE, Wu Q, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260-271.
37. Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613-1621.
38. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003;56:1354-1360.
39. Lujan AE, Mundt AJ, Yamada SD, et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:516-521.
40. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-266.
41. Adli M, Mayr NA, Kaiser HS, et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? Int J Radiat Oncol Biol Phys 2003;57:230-238.
42. Schefter TE, Kavanagh BD, Wu Q, et al. Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim 2002;27:177-184.
43. Galvin JM, Ezzell G, Eisbrauch A, et al. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004;58:1616-1634.